Clemens Hufnagl

Publikationen

Publikationen pro Jahr 2006 2009 2014 2015 2016 2017 2018 2020 2024

• 27 Originalarbeit (Zeitschrift)
• 14 publizierter Abstrakt (Zeitschrift)
• 3 Poster
• 3 nicht-publizierter Abstrakt
• 6 Mehr
  • 3 Letter to the editor
  • 2 Fallbericht
  • 1 Korrektur

Publikationen pro Jahr

Publikationen pro Jahr

Suchergebnisse

• 2022

  Evaluation of a novel flow diverter, the DiVeRt system, in an animal model

  Hufnagl, C. (Erstautor/-in), Broussalis, E. (Co-Autor/-in), Cognard, C., Grimm, J. (Co-Autor/-in), Hecker, C. (Co-Autor/-in), Oellerer, A. (Co-Autor/-in), Abdallah, M. (Co-Autor/-in), Griessenauer, C. (Co-Autor/-in) & Killer-Oberpfalzer, M. (Letztautor/-in), Apr. 2022, in: JOURNAL OF NEUROINTERVENTIONAL SURGERY. 14, 4, S. 384-389 6 S.

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

  • Aneurysm 100%
  • Neck 20%
  • Biocompatibility 20%
  • Antiplatelet 20%
  • Stenosis 20%
  3 Quellenangaben (Web of Science)

• New concept in neurovascular navigation: technical description and preclinical experience with the Bendit 17 and Bendit 21 microcatheters in a rabbit aneurysm model

  Berenstein, A., Cabiri, O., Broussalis, E. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in) & Killer-Oberpfalzer, M. (Letztautor/-in), 2022, in: JOURNAL OF NEUROINTERVENTIONAL SURGERY. 15, 2, S. 172-175 4 S.

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

  • Aneurysm 100%
  • Vascularity 10%
  • Clinical Study 10%
  • Catheterization 10%
  • Vascular Anatomy 10%
  4 Quellenangaben (Web of Science)
• 2021

  Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

  Schlick, K. (Erstautor/-in), Hohla, F. (Co-Autor/-in), Hamacher, F. (Co-Autor/-in), Hackl, H., Hufnagl, C. (Co-Autor/-in), Markus, S., Magnes, T. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Stättner, S., Hauser-Kronberger, C. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Rinnerthaler, G. (Letztautor/-in), 2021, in: FUTURE SCIENCE OA. 7, 2, S. FSO644

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  3 Quellenangaben (Web of Science)
• 2020

  Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

  Hufnagl, C. (Erstautor/-in), Leisch, M. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Moik, M. (Co-Autor/-in), Asslaber, D. (Co-Autor/-in), Roland, G., Steininger, P. (Co-Autor/-in), Meissnitzer, T., Neureiter, D. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2020, in: Oncology Letters. 19, 2, S. 1558

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  8 Quellenangaben (Web of Science)

• Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.

  Neureiter, D. (Erstautor/-in), Mayr, C. R. (Erstautor/-in), Winkelmann, P., Neumayer, B., Klieser, E. (Co-Autor/-in), Wagner, A. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Emmanuel, K. (Co-Autor/-in), Holzinger, J. (Co-Autor/-in), Koch, O. O. (Co-Autor/-in), Kiesslich, T. (Co-Autor/-in) & Varga, M. (Letztautor/-in), 2020, in: CELLS. 9, 2

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  3 Quellenangaben (Web of Science)

• Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.

  Rinnerthaler, G. (Erstautor/-in), Gampenrieder, S. P. (Erstautor/-in), Hackl, H., Steiner, M. (Co-Autor/-in), Monzo-Fuentes, C., Melchardt, T. (Co-Autor/-in), Magnes, T. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Westphal, T. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Hauser-Kronberger, C. (Co-Autor/-in), Egle, A. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2020, in: Journal of Clinical Medicine. 9, 6

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  6 Quellenangaben (Web of Science)
• 2019

  BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.

  Asslaber, D. (Erstautor/-in), Wacht, N. (Co-Autor/-in), Leisch, M. (Co-Autor/-in), Qi, Y., Maeding, N., Hufnagl, C. (Co-Autor/-in), Jansko, B., Zaborsky, N. (Co-Autor/-in), Villunger, A., Hartmann, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2019, in: CLINICAL CANCER RESEARCH . 25, 6, S. 190-1912

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  29 Quellenangaben (Web of Science)
• 2018

  Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

  Melchardt, T. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Thorner, A. R., Ducar, M., Neureiter, D. (Co-Autor/-in), Tränkenschuh, W., Klieser, E. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Rösch, S. (Co-Autor/-in), Rasp, G. (Co-Autor/-in), Hartmann, T. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2018, in: EUROPEAN JOURNAL OF CANCER . 93, S. 69-78

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  25 Quellenangaben (Web of Science)

• DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer

  Gampenrieder, S. P. (Erstautor/-in), Rinnerthaler, G. (Erstautor/-in), Hackl, H., Pulverer, W., Weinhaeusel, A., Ilic, S., Hufnagl, C. (Co-Autor/-in), Hauser-Kronberger, C. (Co-Autor/-in), Egle, A. (Co-Autor/-in), Risch, A. & Greil, R. (Letztautor/-in), 2018, in: Theranostics. 8, 8, S. 2278-2288

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  23 Quellenangaben (Web of Science)

• Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

  Huemer, F. (Erstautor/-in), Thaler, J., Piringer, G., Hackl, H., Pleyer, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Weiss, L. (Letztautor/-in) & Greil, R. (Letztautor/-in), 2018, in: BMC CANCER. 18, 1, S. 11

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  12 Quellenangaben (Web of Science)

• The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.

  Magnes, T. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Hufnagl, C. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Mittermair, C., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Roesch, S. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2018, in: PHARMACOGENOMICS J. 18, 3, S. 479

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  19 Quellenangaben (Web of Science)
• 2017

  Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

  Gampenrieder, S. P. (Erstautor/-in), Hufnagl, C. (Co-Autor/-in), Brechelmacher, S., Huemer, F. (Co-Autor/-in), Hackl, H., Rinnerthaler, G. (Co-Autor/-in), Romeder, F. (Co-Autor/-in), Monzo Fuentes, C. (Co-Autor/-in), Morre, P. (Co-Autor/-in), Hauser-Kronberger, C. (Co-Autor/-in), Mlineritsch, B. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2017, in: PHARMACOGENOMICS J. 17, 4, S. 344-350

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  7 Quellenangaben (Web of Science)
• 2016

  Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

  Melchardt, T. (Erstautor/-in), Hufnagl, C. (Erstautor/-in), Weinstock, D. M., Kopp, N., Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Hackl, H., Weiss, L. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Hartmann, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Weigert, O. & Egle, A. (Letztautor/-in), 2016, in: Oncotarget. 7, 32, S. 51494-51502

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  33 Quellenangaben (Web of Science)

• miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

  Rinnerthaler, G. (Erstautor/-in), Hackl, H., Gampenrieder, S. P. (Co-Autor/-in), Hamacher, F. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Hauser-Kronberger, C. (Co-Autor/-in), Zehentmayr, F. (Co-Autor/-in), Fastner, G. (Co-Autor/-in), Sedlmayer, F. (Co-Autor/-in), Mlineritsch, B. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2016, in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 17, 2

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  68 Quellenangaben (Web of Science)
• 2015

  A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.

  Melchardt, T. (Erstautor/-in), Troppan, K., Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Hopfinger, G. (Co-Autor/-in), Magnes, T. (Co-Autor/-in), Deutsch, A., Neumeister, P., Hackl, H., Greil, R. (Co-Autor/-in), Pichler, M. & Egle, A. (Letztautor/-in), 2015, in: BRITISH JOURNAL OF HAEMATOLOGY . 168, 2, S. 239-245

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  65 Quellenangaben (Web of Science)

• CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.

  Melchardt, T. (Erstautor/-in), Hufnagl, C. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Hutarew, G. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Schlattau, A. (Co-Autor/-in), Moser, G. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2015, in: BMC CANCER. 15, S. 725

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  11 Quellenangaben (Web of Science)

• Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.

  Melchardt, T. (Erstautor/-in), Troppan, K., Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Schlick, K. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Deutsch, A., Neumeister, P., Greil, R. (Co-Autor/-in), Pichler, M. & Egle, A. (Letztautor/-in), 2015, in: JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 13, 12, S. 1501-1508

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  29 Quellenangaben (Web of Science)

• Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.

  Pircher, M., Mlineritsch, B. (Co-Autor/-in), Fridrik, M. A., Dittrich, C., Lang, A., Petru, E., Weltermann, A., Thaler, J., Hufnagl, C. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Ressler, S. (Co-Autor/-in), Ulmer, H. & Greil, R. (Letztautor/-in), 2015, in: ANTICANCER RESEARCH . 35, 1, S. 517-521

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

  10 Quellenangaben (Web of Science)

• Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

  Melchardt, T. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Kemmerling, R., Morre, P. (Co-Autor/-in), Boekstegers, A., Hopfinger, G. (Co-Autor/-in), Auberger, J. (Co-Autor/-in), Steinkirchner, S. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2015, in: LEUKEMIA & LYMPHOMA . 56, 2, S. 353-360

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  3 Quellenangaben (Web of Science)
• 2014

  Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.

  Weiss, L. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Habringer, S., Boekstegers, A., Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Hopfinger, G. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2014, in: ANNALS OF ONCOLOGY . 25, 1, S. 171-176

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  48 Quellenangaben (Web of Science)
• 2013

  A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients.

  Hufnagl, C. (Erstautor/-in), Stöcher, M., Moik, M., Geisberger, R. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2013, in: Journal of nucleic acids investigation. Vol 4, No 1 (2013), S. 1-3

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
• 2012

  Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.

  Langelueddecke, C., Jakab, M. (Erstautor/-in), Ketterl, N., Lehner, L., Hufnagl, C. (Co-Autor/-in), Schmidt, S. (Co-Autor/-in), Geibel, J. P., Fuerst, J. & Ritter, M. (Letztautor/-in), 2012, in: Cellular physiology and biochemistry. 29, 1-2, S. 75-86

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  33 Quellenangaben (Web of Science)
• 2011

  Radon-therapy in ankylosing spondylitis reduces auto-antibody titers

  Moder, A., Hufnagl, C. (Co-Autor/-in), Jakab, M. (Co-Autor/-in), Hitz, W. & Ritter, M. (Letztautor/-in), 2011, in: Open Journal of Molecular and Integrative Physiology. 1 (13), S. 52-54

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
• 2010

  Effect of combined Low-Dose Radon-and Hyperthermia Treatment (LDRnHT) of patients with ankylosing spondylitis on serum levels of cytokines and bone metabolism markers: A pilot study

  Moder, A., Hufnagl, C. (Co-Autor/-in), Lind-Albrecht, G., Hitzl, W. (Co-Autor/-in), Hartl, A. (Co-Autor/-in), Jakab, M. (Co-Autor/-in) & Ritter, M. (Letztautor/-in), 2010, in: International Journal of Low Radiation.

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

• Effect of combined Low-Dose Radon- and Hyperthermia Treatment of Patients with Ankylosing Spondylitis on Serum Levels of Cytokines and Bone Metabolism Markers: A Pilot Study.

  Moder, A., Hufnagl, C. (Co-Autor/-in), Lind-Albrecht, G., Hitzl, W. (Co-Autor/-in), Hartl, A. J. (Co-Autor/-in), Jakab, M. (Co-Autor/-in) & Ritter, M. (Letztautor/-in), 2010, in: International Journal of Low Radiation. 7 (6), S. 423-435

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
• 2009

  The phytostilbene resveratrol induces apoptosis in INS-1E rat insulinoma cells.

  Bortolotti, C., Kunit, T. (Co-Autor/-in), Moder, A., Hufnagl, C. (Co-Autor/-in), Schmidt, S. (Co-Autor/-in), Hartl, A. J. (Co-Autor/-in), Langelueddecke, C., Fürst, J., Geibel, J. P., Ritter, M. (Co-Autor/-in) & Jakab, M. (Letztautor/-in), 2009, in: Cellular physiology and biochemistry. 23, 4-6, S. 2-54

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
  13 Quellenangaben (Web of Science)
• 2006

  Folate supplementation does not affect biochemical markers of bone turnover.

  Herrmann, M., Stanger, O., Paulweber, B. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in) & Herrmann, W., 2006, in: CLINICAL LABORATORY. 52, 3-4, S. 131-136

  Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

  22 Quellenangaben (Web of Science)